Name : FACT0RN (FACT)
FACT Price : $12.016 -23.41%
Consensus Mechanism : Proof of Work
Volume: 140,511
Shariah Judgement
This feature only can be accessed by subscribed users.
Shariah Status :
Last Screening: Q1 2024
Legitimacy:
Project:
Token:
Reward:
Shariah
Legitimacy
People
Shariah Analysis
Project/Products | Use Case | Status |
---|---|---|
Use Case | Status |
---|---|
System | Status | Interpretation |
---|---|---|
Legitimacy Analysis
Details | Status | |
---|---|---|
Whitepaper | ||
Project |
People Analysis
Details | Status | |
---|---|---|
Team |
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Overview
FACT0RN Blockchain, a recipient of the 2022 Coinbase Crypto Community Fund grant, innovatively replaces hashing with integer factorization as Proof of Work (PoW), enhancing security and fostering community engagement. Leveraging RSA cryptography's reliance on integer factorization, FACT0RN introduces a deadpool feature, allowing users to pay FACT coins to submit numbers for factorization. The blockchain's PoW involves mining brilliant numbers in base 2, incentivizing participation through rewards and the ability to contribute to existing factorization tasks. With its unique approach and community-driven ethos, FACT0RN aims to redefine blockchain security and incentivize broader participation in mathematical processes critical to cryptography.
Whitepaper & Documents
Sharlife uses TradingView technology to present price information through charts. TradingView serves as a charting platform catering to a worldwide community of traders and investors. With robust support across browsers, desktops, and mobile applications, the platform offers exceptional access to real-time data such as Dow Futures and BTC USD Chart, as well as the latest news, financial reports, stock screener, and economic .
COMMENTS
0 Comments